Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria

Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria

Abstract Background The use of angiotensin-converting enzyme inhibitors (ACEI) has been associated with the development of bradykinin-mediated angioedema. With ever-widening indications for ACEI in diseases including hypertension, congestive heart failure and diabetic nephropathy, a concomitant incr...

Full description

Bibliographic Details
Main Authors: Nicola Bonner, Charlotte Panter, Alan Kimura, Rich Sinert, Joseph Moellman, Jonathan A. Bernstein
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Health Services Research
Subjects:
Angiotensin-converting enzyme inhibitors (ACEI)
ACEI-Angioedema (ACEI-A)
Severity scoring
Discharge criteria
Rating scale
Online Access:http://link.springer.com/article/10.1186/s12913-017-2274-4

Internet

http://link.springer.com/article/10.1186/s12913-017-2274-4

Similar Items